Research & Development in
Allschwil

29 companies in Research & Development based in Allschwil — name and year of registration from the commercial register. The list below shows them all.

Companies

All 29 companies in Allschwil

Pharmatrans Sanaq AG Logo

Pharmatrans Sanaq AG

Since 1982 · 11–20 empl.

The core activity of Pharmatrans SANAQ AG is the development, manufacture and distribution of excipients and active ingredients for the pharmaceutical industry. The company offers standardized and customer-specific solutions and supports its customers in the development and production of medicinal products.

Research & DevelopmentExcipients and active ingredientsBindersHigh Performance API
ranQ Trust Score 4.1 out of 5.0, rated High, Rank #1
Actelion Pharmaceuticals Ltd Logo

Actelion Pharmaceuticals Ltd

Since 1997 · 21–50 empl.

Actelion Pharmaceuticals Ltd is a pharmaceutical company focused on the research, development, and marketing of medicines. The website presents Johnson & Johnson Innovative Medicine’s therapeutic areas, including oncology, immunology, neuroscience, and cardiopulmonary care.

Research & DevelopmentMedicines and therapiesClinical trialsPatient Resources
ranQ Trust Score 4.1 out of 5.0, rated High, Rank #2
ROLIC Technologies AG Logo

ROLIC Technologies AG

Since 1998 · 11–20 empl.

ROLIC Technologies AG develops and sells ready-to-use formulations and functional films for displays, security documents, and other applications in the optical industry. The company also provides materials for thin-film encapsulation and barrier films.

Research & DevelopmentFormulations and functional filmsPhotoalignment materials
ranQ Trust Score 4.1 out of 5.0, rated High, Rank #3
Vortex Europe AG Logo

Vortex Europe AG

Since 2012 · 1–10 empl.

Vortex Europe AG provides products, technologies and services for trenchless rehabilitation of water and wastewater infrastructure. Its portfolio includes coatings and materials, liner systems, sewer robotics, sensors and software, as well as trenchless installation services.

Research & DevelopmentTrenchless Rehabilitation ProductsTrenchless Rehabilitation ServicesTechnical Support and Training
ranQ Trust Score 4.1 out of 5.0, rated High, Rank #4
OncoGenomX AG Logo

OncoGenomX AG

Since 2019 · 1–10 empl.

OncoGenomX AG provides PredictionStar, a therapy decision-support tool for breast cancer that analyzes tumor-specific genomic, biological, pathological and clinical data to inform treatment composition. The point-of-care platform applies patented algorithms and machine-learning–assisted drug–tumor matching, delivers analysis reports within the hospital IT environment without additional invasive procedures, and is designed for routine clinical use.

Research & DevelopmentTherapy decision support (Prediction Star)Analysis of tumour and patient dataIntelligence-augmented Drug-Tumor-Matching
ranQ Trust Score 4.1 out of 5.0, rated High, Rank #5
DeltaMem AG Logo

DeltaMem AG

Since 2016 · 11–20 empl.5.0(2)

The core activity of DeltaMem AG is the development and supply of membrane technologies and plants for the dehydration of organic solvents in the pharmaceutical, biotechnology, bioenergy and fine chemical industries. In particular, the company focuses on pervaporation and cross-flow filtration to clean and concentrate solvents. DeltaMem AG develops and supplies customized plants and solutions for industry, including membrane modules, process engineering and optimization.

Research & DevelopmentTurnkey solvent recovery plantsPervaporation plantsMembrane development
ranQ Trust Score 4.1 out of 5.0, rated High, Rank #6
InCephalo AG Logo

InCephalo AG

Since 2021 · 1–10 empl.

The core activity of InCephalo Therapeutics is the development and research of local therapies for neurological diseases, particularly brain cancer. The company focuses on the development of biological drugs specifically designed for local application in the central nervous system (CNS) to minimize side effects and maximize efficacy. The proprietary Compartment Lock technology (C-Lock) enables the local retention of biological drugs in the CNS, prolonging their effect while minimizing systemic exposure.

Research & DevelopmentC-Lock™ PlatformC-Locked BiologicsGlioblastoma Therapy (InC01)
ranQ Trust Score 4.0 out of 5.0, rated High, Rank #7
Bright Peak Therapeutics AG Logo

Bright Peak Therapeutics AG

Since 2017 · 51–100 empl.5.0(1)

The core activity of Bright Peak Therapeutics is the development of cancer medications, particularly in the field of immuno-oncology, antibody-drug conjugates (ADCs) and biologics.

Research & DevelopmentDevelopment of multifunctional precision immunotherapiesProtein engineering
ranQ Trust Score 4.0 out of 5.0, rated High, Rank #8
BioConcept AG Logo

BioConcept AG

Since 1988 · 1–10 empl.3.4(7)

The core activity of BioConcept Ltd. is the manufacture and distribution of products and services in the field of biotechnology and life sciences, particularly in the areas of cell culture, molecular biology, immunology and microbiology. This includes the development and production of customer-specific cell culture media, enzymes, antibodies, cell lines, tissue samples and other biological products, as well as the provision of services such as pipette and cycle maintenance.

Research & DevelopmentCell Culture MediaCustomized Cell Culture MediaLaboratory Consumables and Plastics
ranQ Trust Score 4.0 out of 5.0, rated High, Rank #9
DMS Consulting GmbH Logo

DMS Consulting GmbH

Since 2022 · 1–10 empl.

The core activity of VAKUMIN GmbH is the development, manufacture and marketing of high-quality cookware, in particular vacuum cooking pots, which enable energy savings and sustainable kitchen practices through their innovative technology.

Research & DevelopmentCookware (VAKUMIN)PotsPans
ranQ Trust Score 3.9 out of 5.0, rated High, Rank #10
Phialogics AG Logo

Phialogics AG

Since 2022 · 1–10 empl.

Research & Development
ranQ Trust Score 3.9 out of 5.0, rated High, Rank #11
INNOSIAMO AG Logo

INNOSIAMO AG

Since 2024 · 1–10 empl.

INNOSIAMO AG helps startups accelerate innovation in healthcare and create sustainable value through collaborations. The company focuses on supporting innovation projects with impact in the healthcare sector.

Research & DevelopmentInnovation acceleration for healthcare startups
ranQ Trust Score 3.8 out of 5.0, rated High, Rank #12
Crystallise! AG Logo

Crystallise! AG

Since 2017 · 1–10 empl.4.0(1)

The core activity of Crystallise! AG is the crystallization of liquids and the analysis of crystals using X-ray and electron diffraction (micro-ED). The company provides services in the fields of crystallization, structure elucidation and identification of molecules, particularly for the pharmaceutical, chemical and agro-industry. It supports customers in the crystallization of active pharmaceutical ingredients (APIs), co-crystals/salts, polymorphic forms, natural products and other small molecules.

Research & DevelopmentCrystallization ServicesX-ray Measurement and Structure AnalysisElectron Diffraction (micro-ED)
ranQ Trust Score 3.7 out of 5.0, rated Solid, Rank #13
Monix Health AG Logo

Monix Health AG

Since 2025 · 1–10 empl.

Monix Health AG develops a real-time hormone monitoring platform for women that combines a non-invasive wearable biosensor patch with an AI-powered app. The technology continuously detects LH and progesterone, transmits data to devices and clinicians, and is intended to support clinical timing decisions such as during IVF while reducing repeated blood draws.

Research & DevelopmentReal-time hormone monitoring for IVFPlatform for hormone insights and guidance
ranQ Trust Score 3.7 out of 5.0, rated Solid, Rank #14
Nanolynx Biologics AG Logo

Nanolynx Biologics AG

Since 2025 · 1–10 empl.

Nanolynx Biologics AG develops conditionally active nanobody-drug conjugates (CA-NDCs) for hard-to-treat solid tumors. The company uses an AI-enabled discovery platform and focuses on tumor-selective biologics for oncology targets such as CD70, CD142 and Nectin-4.

Research & DevelopmentTumor-activated Nanobody TherapeuticsIntelliBody™ PlatformBiologics Development Partnerships
ranQ Trust Score 3.7 out of 5.0, rated Solid, Rank #15
Gubra GmbH Logo

Gubra GmbH

Since 2026 · 1–10 empl.

Gubra GmbH is a biotechnology company operating through Biotech, CRO services and Ventures. It develops peptide-based drug candidates and provides preclinical research and development services across areas such as obesity, liver, kidney, lung and metabolic diseases.

Research & DevelopmentPreclinical CRO ServicesPreclinical Studies by Disease AreaPreclinical Imaging (3D Imaging)
ranQ Trust Score 3.7 out of 5.0, rated Solid, Rank #16
GlioCART GmbH Logo

GlioCART GmbH

Since 2025 · 1–10 empl.

GlioCART GmbH develops a dual-action CAR-T therapy for glioblastoma. The company focuses on directly attacking tumor cells while also reprogramming the immunosuppressive tumor microenvironment.

Research & DevelopmentCAR-T Therapy for GlioblastomaPipeline of Next-Generation CAR-T Therapies
ranQ Trust Score 3.6 out of 5.0, rated Solid, Rank #17
Swiss Biome Institute GmbH Logo

Swiss Biome Institute GmbH

Since 2025 · 1–10 empl.

Swiss Biome Institute GmbH provides microbiome analysis to support clinical trials in functional foods, biotherapeutics and microbiota research. The institute performs advanced omics analyses (genomics, transcriptomics, proteomics, metabolomics), supports product efficacy validation and R&D project planning and implementation including computational analysis, and conducts epigenetic and mitochondrial research related to longevity using AI and in vivo studies.

Research & DevelopmentMicrobiome analysisResearch and development solutionsOmics analytics
ranQ Trust Score 3.6 out of 5.0, rated Solid, Rank #18
Cancentus GmbH Logo

Cancentus GmbH

Since 2026 · 1–10 empl.

Research & Development
ranQ Trust Score 3.4 out of 5.0, rated Solid, Rank #19
Immuna Therapeutics AG Logo

Immuna Therapeutics AG

Since 2025 · 1–10 empl.

Immuna Therapeutics AG develops cell and gene therapies, with a focus on CAR-T and gene therapy platforms for blood cancers and other indications. The company supports hospitals and health systems with decentralized GMP manufacturing, regulatory support, and commercialization.

Research & DevelopmentCAR-T Cell TherapyDecentralized GMP ManufacturingRegulatory and Compliance Support
No score yet
BIIE AI Initiative AG Logo

BIIE AI Initiative AG

Since 2025 · 1–10 empl.

BIIE AI Initiative AG is the AI initiative of the Botnar Institute of Immune Engineering (BIIE). The website mainly provides privacy policy information and a contact/newsletter form; it contains little detail about specific products or services.

Research & DevelopmentAI Research Initiative for Immune Engineering
No score yet
SS

SRS Schärer Research Services

Since 2002 · 1–10 empl.

Research & Development
No score yet
IR

Intelligence Research Services GmbH

Since 2003 · 1–10 empl.

Research & Development
No score yet
AR

Auxenion Research AG

Since 2017 · 1–10 empl.

Research & Development
No score yet
NG

noul GmbH

Since 2019 · 1–10 empl.

Research & Development
No score yet
TB

Treeline Biosciences GmbH

Since 2023 · 1–10 empl.

Research & Development
No score yet
EA

EqVita AG

Since 2024 · 1–10 empl.

Research & Development
No score yet
SS

Sironax Switzerland GmbH

Since 2025 · 1–10 empl.

Research & Development
No score yet
ZA

Zhang Auberson Clinical Development Consulting

Since 2026 · 1–10 empl.

Management Consulting
No score yet

Research & Development in Allschwil

29Research & DevelopmentCommercial register (Zefix) · as of October 10, 2026
2022Median year of registrationCommercial register (Zefix) · as of October 10, 2026
124in the Canton of Basel-CountryCommercial register (Zefix) · as of October 10, 2026
4,853in SwitzerlandCommercial register (Zefix) · as of October 10, 2026
Locations

Research & Development in the region

Point size by number of companies per place.

Source: commercial register (Zefix) · as of October 10, 2026